Mélanie Laporte

555 total citations
9 papers, 315 citations indexed

About

Mélanie Laporte is a scholar working on Immunology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mélanie Laporte has authored 9 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mélanie Laporte's work include Cancer Genomics and Diagnostics (3 papers), Immunotherapy and Immune Responses (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Mélanie Laporte is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Immunotherapy and Immune Responses (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Mélanie Laporte collaborates with scholars based in France, Canada and United States. Mélanie Laporte's co-authors include Ludovic Lacroix, Éric A. Cohen, Bruno Coutard, Delia Susan‐Resiga, Claudio Nicotra, Françoise Farace, Keith Wilcoxen, Laura Mezquita, Emma Pailler and Alexandra Evagelidis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Virology.

In The Last Decade

Mélanie Laporte

8 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mélanie Laporte France	7	112	100	95	93	74	9	315
Hong-Xin Peng China	12	158 1.4×	186 1.9×	174 1.8×	47 0.5×	66 0.9×	19	420
Birte Möhlendick Germany	14	217 1.9×	134 1.3×	162 1.7×	155 1.7×	53 0.7×	32	502
Malin Berglund Sweden	11	129 1.2×	126 1.3×	27 0.3×	48 0.5×	35 0.5×	15	306
Gongyu Tang United States	6	45 0.4×	238 2.4×	97 1.0×	49 0.5×	60 0.8×	10	322
Kwok-Wah Chan Hong Kong	7	62 0.6×	150 1.5×	36 0.4×	48 0.5×	33 0.4×	9	287
Madeleine Suffiotti Switzerland	9	191 1.7×	69 0.7×	26 0.3×	92 1.0×	42 0.6×	14	425
Mariel García‐Chagollán Mexico	13	52 0.5×	103 1.0×	36 0.4×	110 1.2×	19 0.3×	34	372
Stephen Beil United States	4	46 0.4×	105 1.1×	27 0.3×	95 1.0×	95 1.3×	7	300
Mushfiq Hassan Shaikh Canada	12	123 1.1×	133 1.3×	69 0.7×	38 0.4×	35 0.5×	32	378
Mi Mi China	10	69 0.6×	192 1.9×	169 1.8×	18 0.2×	74 1.0×	12	327

Countries citing papers authored by Mélanie Laporte

Since Specialization

Citations

This map shows the geographic impact of Mélanie Laporte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Laporte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Laporte more than expected).

Fields of papers citing papers by Mélanie Laporte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Laporte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Laporte. The network helps show where Mélanie Laporte may publish in the future.

Co-authorship network of co-authors of Mélanie Laporte

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Laporte. A scholar is included among the top collaborators of Mélanie Laporte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Laporte. Mélanie Laporte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sannier, Gérémy, Alexandre Nicolas, Manon Nayrac, et al.. (2024). Enhanced detection of antigen-specific T cells by a multiplexed AIM assay. Cell Reports Methods. 4(1). 100690–100690. 13 indexed citations

Essalmani, Rachid, Jaspreet Jain, Delia Susan‐Resiga, et al.. (2022). Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity. Journal of Virology. 96(8). e0012822–e0012822. 113 indexed citations

Nicolas, Alexandre, Gérémy Sannier, Mathieu Dubé, et al.. (2022). A Long Interval Between Priming and Boosting SARS-CoV-2 mRNA Vaccine Doses Enhances B Cell Responses With Limited Impact on T Cell Immunity. SSRN Electronic Journal.

Lodge, Robert, Mélanie Laporte, Syim Salahuddin, et al.. (2020). Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107. mBio. 11(5). 15 indexed citations

Pailler, Emma, Vincent Faugeroux, Marianne Oulhen, et al.. (2019). Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK -Rearranged Non–Small-Cell Lung Cancer. Clinical Cancer Research. 25(22). 6671–6682. 92 indexed citations

Pailler, Emma, Laura Mezquita, Vincent Faugeroux, et al.. (2018). Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways.. Journal of Clinical Oncology. 36(15_suppl). 12038–12038. 3 indexed citations

Boussemart, Lise, Isabelle Girault, Hélène Malka-Mahieu, et al.. (2016). Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization. Cancer Research. 76(6). 1476–1484. 33 indexed citations

Deutsch, Éric, Christine Haie-Méder, Mohamed Amine Bayar, et al.. (2016). Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients. Oncotarget. 7(18). 25549–25557. 14 indexed citations

Dieci, Maria Vittoria, Véronique Scott, Guangliang Yin, et al.. (2016). Whole exome sequencing of rare aggressive breast cancer histologies. Breast Cancer Research and Treatment. 156(1). 21–32. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact